{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Treatment of Physicians Choice in participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-3-open-label-study-of-ifinatamab-deruxtecan-versus-treatment-of-physicians-choice-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc\/#breadcrumbitem"}]}